JPH03206052A - 耽溺の症状を処置するための製薬学的組成物及び方法 - Google Patents

耽溺の症状を処置するための製薬学的組成物及び方法

Info

Publication number
JPH03206052A
JPH03206052A JP2298713A JP29871390A JPH03206052A JP H03206052 A JPH03206052 A JP H03206052A JP 2298713 A JP2298713 A JP 2298713A JP 29871390 A JP29871390 A JP 29871390A JP H03206052 A JPH03206052 A JP H03206052A
Authority
JP
Japan
Prior art keywords
per dose
combination
symptoms
pharmaceutical composition
acetaminophen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2298713A
Other languages
English (en)
Japanese (ja)
Inventor
William J Goldman
ウイリアム・ジエイ・ゴールドマン
Thomas N Gates
トマス・エヌ・ゲイツ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23709269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH03206052(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Publication of JPH03206052A publication Critical patent/JPH03206052A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
JP2298713A 1989-11-02 1990-11-02 耽溺の症状を処置するための製薬学的組成物及び方法 Pending JPH03206052A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43083789A 1989-11-02 1989-11-02
US430837 1989-11-02

Publications (1)

Publication Number Publication Date
JPH03206052A true JPH03206052A (ja) 1991-09-09

Family

ID=23709269

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2298713A Pending JPH03206052A (ja) 1989-11-02 1990-11-02 耽溺の症状を処置するための製薬学的組成物及び方法

Country Status (14)

Country Link
EP (1) EP0426479B1 (enExample)
JP (1) JPH03206052A (enExample)
KR (1) KR910009254A (enExample)
AT (1) ATE101515T1 (enExample)
AU (1) AU646230B2 (enExample)
CA (1) CA2028746C (enExample)
DE (1) DE69006684T2 (enExample)
ES (1) ES2057439T3 (enExample)
GR (1) GR1002097B (enExample)
IE (1) IE64953B1 (enExample)
IN (1) IN171746B (enExample)
NZ (1) NZ235877A (enExample)
PT (1) PT95753A (enExample)
ZA (1) ZA908775B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006514049A (ja) * 2002-12-20 2006-04-27 タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド プロトンポンプ阻害剤、ｎｓａｉｄ及び緩衝剤を含む剤形
JP2009517462A (ja) * 2005-12-01 2009-04-30 ユーハン・コーポレイション 胃腸管粘膜損傷の予防または治療用の組成物

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
CA2144155A1 (en) * 1992-09-29 1994-04-14 Robert T. Sims Ibuprofen-h2 antagonist combinations
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
US5648355A (en) * 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
DE19801811B4 (de) * 1998-01-19 2004-12-23 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
US7799766B2 (en) 1998-04-08 2010-09-21 Theta Biomedical Consulting & Development Co., Inc. Composition for treating hormonally-dependent cancers
US7906153B2 (en) 1998-04-08 2011-03-15 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating multiple sclerosis
US20050220909A1 (en) 2004-03-30 2005-10-06 Theoharides Theoharis C Composition for protection against superficial vasodilator flush syndrome
GB9911017D0 (en) * 1999-05-13 1999-07-14 Zeneca Ltd Pharmaceutical compositions
IL145220A0 (en) * 1999-05-20 2002-06-30 Par Pharmaceutical Inc Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AU4973800A (en) * 1999-06-09 2000-12-28 Eli Lilly And Company Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
CZ20032398A3 (cs) * 2001-03-08 2004-02-18 Astrazeneca Ab Nové použití derivátů 6-karboxamidoimidazo [1,2-a] pyridinu
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
DK1411900T4 (da) 2001-06-01 2014-01-27 Pozen Inc Farmaceutiske sammensætninger til den koordinerede frigørelse af NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7923043B2 (en) 2004-03-30 2011-04-12 Theta Biomedical Consulting & Development Co., Inc. Method for protecting humans against superficial vasodilator flush syndrome
EP3090739A1 (en) * 2008-01-04 2016-11-09 Schabar Research Associates LLC Compositions composed of naproxen sodium and nizatidine
KR20110079641A (ko) 2008-09-09 2011-07-07 아스트라제네카 아베 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
MX2011013467A (es) 2009-06-25 2012-02-13 Astrazeneca Ab Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
US9176146B2 (en) 2009-08-03 2015-11-03 Theta Biomedical Consulting & Development Co., Inc. Methods of treating autism spectrum disorders and compositions for same
US9050275B2 (en) 2009-08-03 2015-06-09 Theta Biomedical Consulting & Development Co., Inc. Methods of screening for and treating autism spectrum disorders and compositions for same
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
JP2023534810A (ja) 2020-07-15 2023-08-14 シャバー リサーチ アソシエイツ エルエルシー 急性痛の処置並びに胸やけの重症度及び／又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物
US12514846B2 (en) 2020-07-15 2026-01-06 Schabar Research Associates Llc Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006514049A (ja) * 2002-12-20 2006-04-27 タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド プロトンポンプ阻害剤、ｎｓａｉｄ及び緩衝剤を含む剤形
JP2012107021A (ja) * 2002-12-20 2012-06-07 Takeda Pharmaceuticals Usa Inc プロトンポンプ阻害剤、ｎｓａｉｄ及び緩衝剤を含む剤形
JP2009517462A (ja) * 2005-12-01 2009-04-30 ユーハン・コーポレイション 胃腸管粘膜損傷の予防または治療用の組成物

Also Published As

Publication number Publication date
IN171746B (enExample) 1992-12-26
ZA908775B (en) 1992-07-29
KR910009254A (ko) 1991-06-28
GR900100786A (el) 1992-04-17
EP0426479B1 (en) 1994-02-16
ATE101515T1 (de) 1994-03-15
AU6568990A (en) 1991-05-09
IE64953B1 (en) 1995-09-20
NZ235877A (en) 1992-09-25
CA2028746A1 (en) 1991-05-03
IE903946A1 (en) 1991-05-08
AU646230B2 (en) 1994-02-17
PT95753A (pt) 1991-09-30
DE69006684D1 (de) 1994-03-24
CA2028746C (en) 1995-12-26
DE69006684T2 (de) 1994-06-09
GR1002097B (en) 1995-12-28
EP0426479A1 (en) 1991-05-08
ES2057439T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
US5417980A (en) Pharmaceutical compositions and methods for treating the symptoms of overindulgence
EP0426479B1 (en) Use of a composition for the manufacture of a medicament for curing the symptoms of overindulgence
US5037815A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
JP5241228B2 (ja) 非ステロイド性抗炎症薬、鬱血除去薬および鎮静作用の少ない抗ヒスタミン薬を含む多層錠
US20100048518A1 (en) Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
JPH01503539A (ja) 非鎮静抗ヒスタミン薬を含んでなる咳／風邪用混合物
Pfaffenrath et al. Analgesics and NSAIDs in the treatment of the acute migraine attack
JPH04230330A (ja) 非ステロイド系抗炎症薬によつて起こる胃腸症候の緩和のための薬剤配合物と緩和法
KR20000070733A (ko) 위장 리파아제 억제제의 용도
RU2322262C2 (ru) Композиции нестероидных противовоспалительных лекарственных средств, противозастойных средств и антигистаминов
Huynh et al. Current concepts in acute pain management
JPH04230329A (ja) 非ステロイド系抗炎症薬によつて起こる胃腸痛症候の緩和のための薬剤配合物と緩和法
Ballinger Cytoprotection with misoprostol: use in the treatment and prevention of ulcers
US20120277318A1 (en) Non-steroidal anti-inflammatory drugs for cough
JP5296968B2 (ja) イブプロフェン含有経口用医薬組成物
CN101014333A (zh) 包含洛索洛芬的口服组合物
JP4993998B2 (ja) イブプロフェンを含有する医薬組成物
US20080081798A1 (en) Pharmaceutical combinations for the treatment of head-aches and migraine attacks as well as blisters and packs that contain them
JP2005035995A (ja) イブプロフェン含有経口用組成物
CA2562801A1 (en) Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
JPH01197439A (ja) ある種のｈ↓１およびｈ↓２受容体遮断剤の組合せにより消化管損傷に対して保護された非ステロイド系抗炎症組成物
JPH01197443A (ja) Ｈ↓１ブロッカー、ｈ↓２ブロッカー、ベーターアドレナリン作用剤又はそれらの組み合せ及びアルカリ化剤を含む非ステロイド抗炎症薬剤組成物及び投与方法
JP2011052023A (ja) イブプロフェン含有経口用組成物
HK1078494B (en) Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines
JP2016074659A (ja) 止瀉剤組成物